PCAND3Y Stock Latest News
Private CompaniesAndelyn Selected for Huntington’s Gene Therapy Manufacturing Program1d agoAND3Y
Private CompaniesAndelyn Biosciences Highlights Path to Commercial Gene Therapy Manufacturing3d agoAND3Y
Private CompaniesAndelyn Manufactures Fayuvi for Sanfilippo Syndrome Treatment4d agoAND3Y
Private CompaniesAndelyn and Celliaz Advance AAV Therapy for Retinitis Pigmentosa1w agoAND3Y
Private CompaniesAndelyn Biosciences Supports Rare-Disease Families Through Giving Campaign1w agoAND3Y
Private CompaniesCommunity-Driven Philanthropy Underscores Andelyn Biosciences’ Social Impact Focus1M agoAND3Y
Private CompaniesAndelyn Biosciences Promotes Rare Disease Philanthropy at Meeting on the Mesa1M agoAND3Y
Private CompaniesAndelyn Biosciences Highlights Rare Disease Development Support Toolkit1M agoAND3Y
Private CompaniesWebinar Highlights Andelyn Biosciences’ Focus on Viral Vector Manufacturing Strategy1M agoAND3Y
Private CompaniesAndelyn Biosciences Emphasizes Functional Lentivirus Manufacturing Strategy2M agoAND3YPrivate CompaniesAndelyn Biosciences Supports Commercialization of Ultragenyx Gene Therapy2M agoAND3Y
Private CompaniesRare Disease Philanthropy Underscores Andelyn Biosciences’ Gene Therapy Focus2M agoAND3Y
Private CompaniesAndelyn Biosciences – Weekly Recap2M agoAND3Y
Private CompaniesAndelyn Biosciences Underscores Gene Therapy Focus and Patient Access in Rare Disease2M agoAND3Y
Private CompaniesPlasmid Manufacturing Capabilities Signal Scaling Focus at Andelyn Biosciences2M agoAND3Y
Private CompaniesAndelyn Biosciences Secures Manufacturing Role in Genprex Diabetes Gene Therapy Program2M agoAND3Y



